Research Areas

Research Areas

KliniPharm is dedicated to innovative research with a focus on natural compounds, particularly novel substances derived from marine flora. KliniPharm’s scientists have years of experience in marine biotechnology, biopharmaceutics, and pharmacology. Partnering with international academic institutions and pharmaceutical companies, and incorporating broad knowledge of natural medicine, KliniPharm scientists have united nature and science to promote health and well-being.

Marine Research | Dermatological and Drug Delivery Research | Pharmaceutical Research

KliniPharm has collaborated with research institutes and industrial companies to advance pharmaceutical applications of our patented marine substances. We have developed product prototypes for the treatment of inflammatory diseases of the skin and gastrointestinal tract, including psoriasis, neurodermatitis, ulcerative colitis, Crohn’s disease, as well as products to promote wound healing. KliniPharm has also established pharmaceutical applications for its patented vesigel® technology for effective transdermal delivery of active substances.

KliniPharm has developed enteric-coated lecithin combined with our patented sponge collagen for a novel nutriceutic treatment that calms irritation in intestines by adhering to inflamed areas and promoting the healing process.

KliniPharm currently has two lead products, developed in collaboration with corporate partners, which have demonstrated efficacy in wound healing in preclinical studies and in small patient samples with deep wounds or bed sores. Unlike animal collagen, marine collagen allows tissue to heal from the center of the wound, reducing the risk of infection.

In proof-of-concept studies, KliniPharm has demonstrated higher release rates and a superior bioavailability of its patented vesigel® technology. Lipophilic active ingredients such as progesterone, estradiol, testosterone and others are excellently absorbed through the skin. In comparison with other bases or commercial preparations, the substances enclosed in sponge collagen-liposomal complexes can be administered in lower doses. This reduces the risk of side effects and optimizes the tolerability of the active ingredients.